Angiotech Pharmaceuticals, Inc.

Angiotech Pharmaceuticals, Inc.

Angiotech Pharmaceuticals is teaching old devices new tricks. The firm develops medical products that combine devices with drugs to make them more effective with fewer side effects. Its flagship product in the Pharmaceutical Technologies segment is the TAXUS drug-eluting stent, which Boston Scientific sells and for which it pays Angiotech royalties. The stent is used to open up diseased arteries, and the drug coating keeps scar tissue from forming and creating a new blockage. The company's Medical Products segment makes the Quill wound closure system and other single-use medical products for interventional radiology, ophthalmology, and surgery. Angiotech has facilities in North America and Europe.

Contact Details

Office Address

Angiotech Pharmaceuticals, Inc.
1618 Station Street
Vancouver, BC, Canada V6A1B6
Phone: (604) 221-7676
Fax: (604) 221-2330

Executives

Chairman

David T. Howard

President, CEO, and Director

William L. Hunter

Business Reviews for Angiotech Pharmaceuticals, Inc.

Related Companies